PELD Score (Pediatric End-Stage Liver Disease)
Predicts mortality in children under 12 years old with end-stage liver disease. Used for liver transplant priority listing (similar to MELD for adults). Higher score = higher mortality risk.
Score interpretation
PELD ≤10 — lower 90-day wait list mortality
→ Continue medical management; close monitoring; transplant centre follow-up
PELD 11–19 — intermediate wait list mortality (~6% at 90 days)
→ Active transplant listing; optimise nutrition; manage complications (ascites, HE, SBP prophylaxis)
PELD ≥20 — high 90-day wait list mortality
→ Priority liver transplant listing; intensive medical support; nutritional supplementation; consider exception points if applicable
Interpretation bands for the PELD Score. Apply clinical judgement and local guidance.
References
- McDiarmid SV et al. PELD: Predicting death in infants and children with liver disease. Am J Transplant. 2002;2(4):308–313.
Related
Curated clinical cross-links plus same-class fallbacks.
- Ibuprofen (Paediatric) · NSAID / Analgesic / Antipyretic
- Paracetamol (Paediatric) · Analgesic / Antipyretic — First-Line Pain and Fever in Children
- Morphine (Paediatric) · Opioid Analgesic — Moderate to Severe Pain in Children
- Gentamicin (Paediatric) · Aminoglycoside — Neonatal Sepsis / Gram-Negative Infections in Children
- Vancomycin (Paediatric) · Glycopeptide Antibiotic — MRSA / Severe Gram-Positive Infections in Children
- Iron Supplementation (Paediatric) · Iron Supplement — Iron Deficiency Anaemia in Children
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.